Open Access

Upregulation of TRPM7 augments cell proliferation and interleukin-8 release in airway smooth muscle cells of rats exposed to cigarette smoke

  • Authors:
    • Xiaoling Lin
    • Cheng Yang
    • Linjie Huang
    • Ming Chen
    • Jianting Shi
    • Lihua Ouyang
    • Tiantian Tang
    • Wei Zhang
    • Yiqun Li
    • Ruiyun Liang
    • Shanping Jiang
  • View Affiliations

  • Published online on: April 22, 2016     https://doi.org/10.3892/mmr.2016.5161
  • Pages: 4995-5004
  • Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Proliferation and synthetic function (i.e. the capacity to release numerous chemokines and cytokines) of airway smooth muscle cells (ASMCs) are important in airway remodeling induced by cigarette smoke exposure. However, the molecular mechanism has not been clarified. Transient receptor potential cation channel subfamily M member 7 (TRPM7) is expressed ubiquitously and is crucial for the cellular physiological function of many cell types. The present study aimed to detect the expression of TRPM7 in ASMCs from smoke‑exposed rats and determine the importance of TRPM7 in proliferation and interleukin‑8 (IL‑8) release. ASMCs were isolated and cultured from smoke‑exposed rats. Expression levels of TRPM7 were determined by reverse transcription‑polymerase chain reaction, western blot analysis and immunofluorescence. TRPM7 was silenced with TRPM7‑short hairpin RNA lentivirus vector. DNA synthesis, cell number and IL‑8 release of ASMCs induced by cigarette smoke extract (CSE) and tumor necrosis factor‑α (TNF‑α) were assessed using [3H]-thymidine incorporation assay, hemocytometer and enzyme‑linked immunosorbent assay, respectively. It was determined that mRNA and protein expression levels of TRPM7 were increased in ASMCs from smoke‑exposed rats. Stimulation with CSE or TNF‑α elevated DNA synthesis, cell number and IL‑8 release were more marked in ASMCs from smoke‑exposed rats. Silencing of TRPM7 reduced DNA synthesis, cell number and IL‑8 release induced by CSE or TNF‑α in ASMCs from smoke-exposed rats. In conclusion, expression of TRPM7 increased significantly in ASMCs from smoke‑exposed rats and the upregulation of TRPM7 led to augmented cell proliferation and IL-8 release in ASMCs from rats exposed to cigarette smoke.

Introduction

Chronic obstructive pulmonary disease (COPD) is characterized by persistent and progressive airflow limitation, which is associated with chronic airway inflammation and parenchymal destruction (1). When exposed to chronic irritants such as cigarette smoke (a common risk factor of COPD) repeated injury and repair, and chronic inflammatory response of the airway wall result in structural changes termed airway remodeling (2,3). Airway smooth muscle (ASM) is one of the important structures of airway wall, and contributes to the chronic inflammatory response and airway remodeling in COPD due to its proliferation and synthetic capabilities (4).

Many cytokines, chemokines and growth factors promote ASM cell (ASMC) proliferation (5) and exposure to cigarette smoke extract (CSE) induces a proliferative phenotype of cultured ASMCs (6). In addition, ASMCs provide cytokines in the airway by releasing eotaxin, chemokine (C-C motif) ligand 5, monocyte chemoattractant proteins, interleukin-6 (IL-6) and IL-8 (7). Pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), and CSE lead to increased expression of various cytokines from ASM (8,9). The release of IL-8, an important neutrophil chemoattractant, from ASMCs and inflammatory cells is important in the pathogenesis of COPD (10). However, the underlying mechanisms of ASM proliferation and synthetic function induced by cigarette smoke exposure have not been elucidated.

Although a wide variety of ion channels are expressed in ASMCs to regulate its biological activities, the precise function of the majority of channels requires investigation. Transient receptor potential cation channel subfamily M member 7 (TRPM7) is a non-selective ion channel permeable to various divalent cations (such as Mg2+ and Ca2+) with a distinctive serine/threonine protein kinase domain in its C-terminal (1113). This channel is highly expressed in the brain, heart, liver, kidney and lung of mammals (14,15) and it has been determined that TRPM7 is important for cellular survival and proliferation of numerous cell types (16). Additionally, in our previous study, it was identified that inhibition of TRPM7 reduced the release of cytokines in rat bone marrow-derived mast cells (17). However, to the best of our knowledge, the association between TRPM7 and ASM with cigarette smoke exposure has not previously been investigated. The aim of the present study was to detect the expression of TRPM7 in ASMCs from rats exposed to cigarette smoke. Furthermore, the role of TRPM7 in cell proliferation and IL-8 release was investigated in the ASMCs.

Materials and methods

Animals

A total of 24 five- to six-week-old male Sprague-Dawley (SD) rats (weight, 150–180 g) were obtained from the Laboratory Animal Center of Sun Yat-sen University (Guangdong Experimental Animal Testing, Guangzhou, China; certificate no. 0101668). The rats were housed in a temperature-controlled room (26±1°C) and maintained on a 12-h light/dark cycle with free access to water and food. All the experiments described were performed in accordance with the regulations of the Centre of Animal Experiments of Sun Yat-sen University. Ethical approval for this investigation was obtained from the Research Ethics Committee, Sun Yat-sen University (Guangzhou, China).

Cigarette smoke exposure

The rats were randomly divided into the smoke-exposed group and control groups (n=12). The rats of the smoke-exposed group were placed in a plastic chamber and exposed to 3R4F research cigarette smoke (University of Kentucky, Lexington, KY, USA), one cigarette twice a day, with one day off every week, for 90 days. The control rats were placed in another plastic chamber and exposed to fresh air over the same time period. All rats were sacrificed by cervical dislocation following CO2 narcosis after the 90-day period for CSE (or fresh air for the control group) was completed. CSE was prepared by burning two 3R4F research cigarettes without a filter and passing the smoke to a 50 ml conical tube containing 20 ml culture medium (Guangzhou Whiga Technology Co., Ltd., Guangzhou, China) at a rate of 5 min/cigarette. The obtained solution was filtered through a 0.22-μm filter and was referred to as 100% strength CSE.

Lung histology and immunohistochemical staining

Lung tissue samples (5 μm) of right lobe was removed from the rats. The tissue samples were fixed with 10% neutral buffered formalin (Guangzhou Whiga Technology Co., Ltd.) and the specimens were dehydrated (by incubating sequentially for 2 h in 75%, 85%, 95% and 100% alcohol, in turn) and embedded in paraffin (Guangzhou Whiga Technology Co., Ltd.). Fixed embedded tissue sections (size, 5 μm) were sliced, placed on glass slides and deparaffinized. Subsequently, α-smooth muscle actin immunohistochemical staining with monoclonal mouse anti-α-smooth muscle actin antibody (1:100; Thermo Fisher Scientific, Inc., Waltham, MA, USA) was used to determine smooth muscle cells in the lung. The ASM areas were stained brown as a result of the α-smooth muscle actin immunohistochemical staining. The ASM areas (μm2) of eight independent bronchioles were measured using Image-Pro Plus version 6.0 software (Media Cybernetics, Inc., Rockville, MD, USA). The results are expressed as a proportion of the total airway area [i.e. the lumen plus the airway wall for the external area at the adventitial border (μm2)].

Isolation and culture of ASMCs

ASMCs were obtained from the trachea and bronchi of smoke-exposed and control SD rats as previously described (18,19). Briefly, the trachea and main bronchi were removed and separated from the lung, bronchial vessels and connective tissue, then dissected into cubes (dimension, 1×1×1 mm). All segments were cultured with Gibco Dulbecco's modified Eagle's medium (DMEM; Thermo Fisher Scientific, Inc.) supplemented with 20% fetal calf serum (FCS; Gibco; Thermo Fisher Scientific, Inc.), 100 U/ml penicillin (Guangzhou Whiga Technology Co., Ltd., Guangzhou, China) and 100 mg/ml streptomycin (Guangzhou Whiga Technology Co., Ltd.) in conditions of 37°C and 5% CO2 for 5 days. Cells were grown to 80% confluence (observed under an inverted phase contrast microscope; Leica Microsystems Wetzlar GmbH, Wetzlar, Germany), the medium was removed, the explants were washed twice with Gibco Hank's Balanced Salt Solution (Thermo Fisher Scientific, Inc.) and trypsinized (in 1 ml of a 0.25% trypsin solution; Guangzhou Whiga Technology Co., Ltd.) for 1 min. Next, ASMCs were cultured in DMEM medium supplemented with penicillin and streptomycin at the above-mentioned concentrations and 10% FCS. The medium was replaced every 2 days. ASMCs were identified by the characteristic hill-and-valley appearance and α-smooth muscle actin immunocytochemical staining. Experiments were performed on freshly isolated ASMCs.

Immunocytochemistry

ASMCs were identified by α-smooth muscle actin immunocytochemical staining, as previously described (18,19). Briefly, ASMCs were seeded onto sterile glass coverslips and grown to 70% confluence. Cells were fixed in 4% paraformaldehyde for 20 min, and the sections were reacted with 3% H2O2 (Guangzhou Whiga Technology Co., Ltd.) After a rinse in phosphate-buffered saline (PBS), the sections were blocked with 2% bovine serum albumin (BSA; Guangzhou Whiga Technology Co., Ltd.) and incubated with monoclonal mouse anti-α-smooth muscle actin antibody (1:300; Thermo Fisher Scientific, Inc.) at 4°C overnight for immunolabeling. Subsequently, the sections were incubated with a secondary horseradish peroxidase (HRP)-conjugated rabbit anti-mouse IgG (1:300; Cell Signaling Technology, Inc., Danvers, MA, USA) for 30 min at 37°C and then washed three times with PBS. The peroxidase activity was visualized by a color reaction using 3,3′-diaminobenzidine (1 ml; Wuhan Boster Biological Technology, Ltd., Wuhan, China) as the substrate. The slides were then counterstained with hematoxylin (Wuhan Boster Biological Technology, Ltd.), mounted and examined under a microscope (Olympus Corp., Tokyo, Japan) using AxioVision 4.1 software (Carl Zeiss Microscopy, LLC, Thornwood, NY, USA).

Reverse transcription-polymerase chain reaction (RT-PCR)

Total RNA was extracted from ASMCs according to the instructions of the TRIzol Reagent kit (Invitrogen; Thermo Fisher Scientific, Inc.). RT-PCR was performed using the SuperScript One-step RT-PCR system (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. There were 35 cycles of 90°C for 35 sec, 56°C for 30 sec and 72°C for 30 sec. β-actin served as an internal control. The primers were as follows: Forward, 5′-CTGAAGAGGAATGACTACAC-3′ and reverse, 5′-ACAGGAAAAAGAGAGGGAG-3′ for TRPM7 [(GenBank, AC000071) Invitrogen; Thermo Fisher Scientific, Inc.]; forward, 5′-TGAGCTGCGTGTGGCCCCTGAG-3′ and reverse, 5′-GGGGCATCGGAACCGCTCATTG-3′ for β-actin [(GenBank, AC000080) Applied Biosystems; Thermo Fisher Scientific, Inc.].

Western blot analysis

ASMCs were lysed with radioimmunoprecipitation assay lysis buffer (Beyotime Institute of Biotechnology, Shanghai, China). The extracts were collected and protein concentrations were measured using a bicinchoninic acid protein assay kit (Wuhan Boster Biological Technology, Ltd.). Equal quantities (40 μg) of protein were separated by 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (Wuhan Boster Biological Technology, Ltd.) and blotted onto polyvinylidene fluoride (PVDF) membrane (Merck Millipore, Bedford, MA, USA). The PVDF membrane was blocked for nonspecific protein binding with Tris-buffered saline/Tween-20 (TBST; Guangzhou Whiga Technology Co., Ltd.) and 5% non-fat milk (Guangzhou Whiga Technology Co., Ltd.) at room temperature for 2 h. Then, the membrane was incubated overnight at 4°C with primary goat anti-TRPM7 (1:500; Abcam, Cambridge, UK) and primary mouse anti-β-actin (1:1,000; Sigma-Aldrich, St. Louis, MO, USA) monoclonal antibodies. Next, the membranes were washed with TBST, incubated with HRP-conjugated rabbit anti-goat IgG (1:500) and rabbit anti-mouse IgG (1:1,000) secondary antibodies (Cell Signaling Technology, Inc.) for 1 h, and then washed three times with TBST. The proteins were detected using an enhanced chemiluminescence system (a SignalBoost™ Immunoreaction Enhancer kit; Merck Millipore).

Detection of TRPM7 protein levels in ASMCs using immunofluorescence

ASMCs were fixed in cold acetone (4°C) for 5 min and washed with 0.01 mol/l PBS (Guangzhou Whiga Technology Co., Ltd.) and immersed in 0.3% Triton X-100 (Guangzhou Whiga Technology Co., Ltd.) in PBS. Subsequently, ASMCs were blocked with 1% BSA in PBS for 1 h at room temperature and incubated with primary monoclonal goat anti-TRPM7 antibody (1:100; Abcam) in PBS containing 3% BSA for 24 h (4°C). Following a wash with PBS at 4°C, ASMCs were labeled with the fluorescein isothiocyanate-conjugated secondary monoclonal donkey anti-goat IgG antibody (1:100; Jackson ImmunoResearch Laboratories, Baltimore, MA, USA) 1 h at room temperature. The nuclei of ASMCs were stained with Hoechst stain (Beyotime Institute of Biotechnology, Shanghai, China).

Design of shRNA against rat TRPM7

Short hairpin RNA (shRNA) targeting the rat TRPM7 gene (TRPM7-shRNA) was designed and synthesized by Guangzhou Forevergen Co., Ltd. (Guangzhou, China) and the sequences were as follows: Forward, 5′-GATCCCCGTCGTTTCTTCCAGAGGTGTTCAAGAGACACCTCTGGAAGAAACGACTTTTTA-3′ and reverse, 5′-AGCTTAAAAAGTCGTTTCTTCCAGAGGTGTCTCTTGAACACCTCTGGAAGAAACGACGGG-3′. The control shRNA contained scrambled sequences (scramble-shRNA) as follows: Forward, 5′-GATCCCCGCCAGCTTAGCACTGACTCTTCAAGAGAGAGTCAGTGCTAAGCTGGCTTTTTA-3′ and reverse, 5′-AGCTTAAAAAGCCAGCTTAGCACTGACTCTCTCTTGAAGAGTCAGTGCTAAGCTGGCGGG-3′.

Generation of lentivirus vectors and transduction of ASMCs

The lentivirus vectors were constructed as previously described (17). Briefly, 293T human kidney cells (Invitrogen; Thermo Fisher Scientific) in 10-cm culture dishes were cotransfected with 10 μg pLV vector, 4.8 μg pGag-Pol, 1.8 μg pRev and 2.7 μg pMDG (Guangzhou Forevergen Co., Ltd.) using Lipofectamine 2000 reagent (Invitrogen; Thermo Fisher Scientific, Inc.). The supernatants were collected 48 and 72 h after transfection, filtered through a 0.4-μm membrane and the viruses were concentrated using an Amicon Ultra-15 100 kDa filter (Merck Millipore). Transduction of ASMCs with lentivirus vectors was performed in the presence of 10 μg/ml polybrene (Sigma-Aldrich). Using pLV vectors with puromycin marker (a coding sequence of the lentivirus vector, obtained from Guangzhou Forevergen Co., Ltd.), cells were selected with 2 μg/ml puromycin (Merck Millipore) following transduction for 24 h. The floating cells were removed, and the remaining attached cells were analyzed and collected for further experiments.

[3H]-thymidine incorporation assay

ASMCs were plated in 24-well cluster plates at a density of 1×105 cells/well in a medium containing 10% FCS and grown to 95% confluence. ASMCs were stimulated with CSE (5 or 15%) or TNF-α (1 ng/ml; Sigma-Aldrich) for 24 h. Then the cells were cultured with [3H]-thymidine (0.25 μCi/ml; GE Healthcare Life Sciences, Chalfont, UK) for 24 h, harvested onto glass-fiber filters (Merck Millipore), and washed twice with PBS and twice with ice-cold 5% trichloroacetic acid (Guangzhou Whiga Technology Co., Ltd.). Subsequently, the cells were dissolved in 0.5 ml NaOH (1 M). Incorporated [3H]-thymidine was quantified by liquid-scintillation counting (Beckman Coulter Inc., Brea, CA, USA).

Cell number determination

ASMCs were plated in 24-well cluster plates at a density of 1×105 cells/well in medium containing 10% FCS and grown to 95% confluence. Then the cells were stimulated with CSE (5 or 15%) or TNF-α (1 ng/ml) for 24 h. ASMCs were harvested and viable cells were counted in duplicate, using a hemocytometer (Guduo Biotechnology Co., Ltd., Shanghai, China). Trypan blue exclusion assay was performed by mixing 80 μl cell suspension and 20 μl 0.4% Trypan Blue Solution (Sigma-Aldrich) for 2 min. Blue cells were counted as dead cells and the cells that did not absorb the dye were counted as living cells.

Measurement of IL-8 in ASMCs

ASMCs were plated in 24-well cluster plates, washed with PBS and stimulated with CSE (5 or 15%) for 24 h or TNF-α (1 ng/ml) for 1 h. Release of IL-8 in the ASMCs culture supernatants was measured using a specific IL-8 enzyme-linked immunosorbent assay (ELISA) kit (Sanquin, Amsterdam, Netherlands) according to the manufacturers' protocol.

Statistical analysis

Data are presented as mean ± standard error of the mean. Statistical significance was determined by Student's t-test for unpaired observations or one-way analysis of variance followed by Bonferroni's post-hoc test for independent observations. P<0.05 was considered to indicate a statistically significant difference.

Results

ASMC proliferation in rats exposed to cigarette smoke

The lung tissue of rats was collected for pathological analysis and α-smooth muscle actin immunohistochemical staining. Morphological observations were performed under a light microscope (Fig. 1). The structure of the alveoli was mostly undamaged, the bronchioles were clear (i.e. there was no infiltration of inflammatory cells in bronchioles of control rats without CSE), and the bronchioles of normal control rats exhibited eumorphism in terms of their cell structure and histology. By contrast, pulmonary emphysema manifested as alveolar wall thinning, alveolar structure disruption, and alveolar space enlargement and fusion were observed in rats that had been exposed to cigarette smoke. Additionally, bronchial epithelial hyperplasia, submucosal inflammatory cell infiltration, and airway wall and ASM thickening were observed in rats exposed to cigarette smoke.

An increase in ASM mass was observed in rats exposed to cigarette smoke when compared with normal rats [the ratio of the ASM area to the total airway area was 0.1645±0.01016 vs. 0.0479±0.00889 (n=8) for CSE rats compared with normal rats; respectively; t=70.139; P<0.001].

TRPM7 is upregulated in ASMCs from smoke-exposed rats

The expression of TRPM7 in primary ASMCs was detected by RT-PCR, western blot analysis and immunofluorescence. As indicated by Fig. 2, the TRPM7 mRNA level was elevated in ASMCs of smoke-exposed rats when compared with normal rats. Furthermore, the western blot analysis indicated increased TRPM7 protein levels in ASMCs in smoke-exposed rats compared with normal rats (Fig. 3). Additionally, immunofluorescence demonstrated increased expression levels of TRPM7 proteins in ASMCs from smoke-exposed rats when compared with normal rats (Fig. 4).

Silencing of TRPM7 in ASMCs by TRPM7-shRNA lentivirus vector

TRPM7 protein expression was detected by western blotting in ASMCs infected with the TRPM7-shRNA lentivirus vector. As indicated by Fig. 5, treatment with TRPM7-shRNA lentivirus vector resulted in a significant decrease in TRPM7 protein expression.

Upregulation of TRPM7 augments proliferation of ASMCs from smoke-exposed rats

ASMCs were stimulated with CSE (5% or 15%) or TNF-α (1 ng/ml) for 24 h. To assess the proliferation of ASMCs, DNA synthesis and cell number of ASMCs were determined by [3H]-thymidine incorporation assay and with a hemocytometer, respectively. As indicated by Fig. 6, stimulation with CSE (5%) did not induce increased DNA synthesis or ASMC number. However, treatment with TRPM7-shRNA lentivirus vector significantly reduced methyl-[3H]-thymidine incorporation and the cell number of ASMCs compared with ASMCs that were not treated with the TRPM7-shRNA lentivirus vector. These observations indicated that TRPM7 is required for ASMC proliferation.

Stimulation with CSE (15%) induced significantly increased DNA synthesis and ASMC number, which was not alleviated by treatment with TRPM7-shRNA lentivirus vector (Fig. 7). When compared with ASMCs from normal rats, the CSE (15%)-induced increases of methyl-[3H]-thymidine incorporation and cell number were significantly enhanced in ASMCs from smoke-exposed rats, as demonstrated by greater expression levels of TRPM7. Treatment with TRPM7-shRNA lentivirus vector reduced methyl-[3H]-thymidine incorporation and cell number of ASMCs. These results indicated that upregulation of TRPM7 augmented proliferation of ASMCs induced by CSE (15%) in smoke-exposed rats. However, in ASMCs treated with TRPM7-shRNA lentivirus vector, stimulation with CSE (15%) induced significantly increased cell number of ASMCs from smoke-exposed rats when compared with normal rats.

As indicated by Fig. 8, stimulation with TNF-α (1 ng/ml) led to increased DNA synthesis in ASMCs, this increase was enhanced significantly in ASMCs from smoke-exposed rats with higher expression levels of TRPM7. However, stimulation with TNF-α (1 ng/ml) induced a significant increase in ASMC number in smoke-exposed rats, but not in ASMC number in normal rats. Treatment with TRPM7-shRNA lentivirus vector reduced methyl-[3H]-thymidine incorporation and cell number of ASMCs. This indicated that upregulation of TRPM7 augmented proliferation of ASMCs induced by TNF-α (1 ng/ml) in smoke-exposed rats. However, increased methyl-[3H]-thymidine incorporation and cell number of ASMCs from smoke-exposed rats induced by TNF-α was not completely inhibited by treatment with TRPM7-shRNA lentivirus vector.

Upregulation of TRPM7 augments IL-8 secretion in ASMCs from smoke-exposed rats

ASMCs were stimulated with CSE (5% or 15%) for 24 h or TNF-α (1 ng/ml) for 1 h and the IL-8 release was determined using an ELISA. Stimulation with CSE (5%) did not increase IL-8 release significantly and treatment with TRPM7-shRNA lentivirus vector did not affect IL-8 release in the ASMCs.

Stimulation with CSE (15%) or TNF-α (1 ng/ml) significantly increased the secretion of IL-8 in ASMCs was not inhibited by treatment with TRPM7-shRNA lentivirus vector (Figs. 9 and 10). Compared with ASMCs from normal rats, the increase of IL-8 secretion induced by CSE (15%) or TNF-α was greater in ASMCs from smoke-exposed rats with higher levels of TRPM7 expression. Treatment with TRPM7-shRNA lentivirus vector reduced IL-8 release, which was induced by CSE (15%) and TNF-α in ASMCs. These results indicated that upregulation of TRPM7 augmented CSE (15%)- or TNF-α-induced IL-8 secretion in ASMCs from smoke-exposed rats. However, in ASMCs treated with the TRPM7-shRNA lentivirus vector, stimulation with CSE (15%) or TNF-α also induced a significant increase in IL-8 secretion in ASMCs from smoke-exposed rats when compared with normal rats.

Discussion

The present study demonstrated that TRPM7 was upregulated in ASMCs from rats exposed to cigarette smoke. The TRP channel is a superfamily of ion channels that control the passage of various ions across membranes (11). These channels are homo- or heterotetramers formed by proteins, which contain six putative transmembrane domains and a pore-forming loop between the fifth and sixth segments. TRPM7 is a widely expressed member of the TRP superfamily. Previous studies have indicated that TRPM7 is expressed in various cell types, including lymphocytes (20), neurons (21), vascular smooth muscle cells (22), vascular endothelia (23), mast cells (24), fibroblasts (25), kidney cells (26) and adipocytes (27). In the present study, RT-PCR, western blot assays and immunofluorescence demonstrated that TRPM7 was expressed in ASMCs from normal rats and the expression levels of TRPM7 were markedly higher in ASMCs from smoke-exposed rats.

The results of the current study identified that upregulation of TRPM7 augmented proliferation in ASMCs from smoke-exposed rats. The function of TRPM7 in cellular proliferation varies between different cell types. In certain types of cells, TRPM7 exhibits a cell death function; for example, TRPM7 leads to cell death in anoxic neurons (21). However, TRPM7 is also required for cell survival and proliferation in various cell types. Previously, it was reported that TRPM7 suppression by retrovirus-mediated siRNA targeting the TRPM7 gene decreased the survival rate of RBL-2H3 cells (28). Additionally, TRPM7 is required for the proliferation of various types of normal and cancer cell, including human mast (24), B lymphocyte (20), human head and neck carcinoma (29), breast cancer (30), hepatocellular carcinoma (31), gastric cancer (32) and prostate cancer (33) cells. Consistent with the majority of results regarding the underlying mechanisms of cellular proliferation, in the current study, silencing of TRPM7 reduced DNA synthesis and cell number of ASMCs, and upregulation of TRPM7 augmented cell proliferation in ASMCs from rats exposed to cigarette smoke.

To the best of our knowledge, this is the first study regarding the importance of TRPM7 in cytokine secretion by ASMCs. In our previous study, it was determined that knockdown of TRPM7 reduced the release of cytokines in rat bone marrow-derived mast cells (17). Therefore, the present study determined that silencing of TRPM7 with TRPM7-shRNA lentivirus vector reduced IL-8 release in ASMCs induced by CSE (15%) and TNF-α in ASMCs from rats exposed to cigarette smoke. Furthermore, the increase of IL-8 secretion induced by CSE and TNF-α was enhanced in ASMCs from rats exposed to cigarette smoke, as demonstrated by higher expression levels of TRPM7. This suggests that upregulation of TRPM7 augmented the release of IL-8 in ASMCs from rats exposed to cigarette smoke. As IL-8 is important in neutrophil recruitment, the upregulation of TRPM7 in ASMCs from rats exposed to cigarette smoke may contribute to the inflammatory response of the airway.

The present study investigated the proliferation of ASMCs and IL-8 release induced by TNF-α due to the association between cigarette smoke exposure and TNF-α. The level of TNF-α is often associated with smoking status, systemic inflammation and airflow limitation in patients with COPD (34,35). In animal models, mice with knocked-out TNF-α receptors did not develop an inflammatory response following acute cigarette smoke exposure (36). Furthermore, it was previously demonstrated that TNF-α accounts for the majority of inflammatory cell infiltration in a mouse model with 6-month smoke exposure (37). However, the mitogenic effect of TNF-α on ASMCs is controversial. A previous study reported that TNF-α promotes ASMC proliferation, which was mediated via the phosphatidylinositol 3-kinase signaling pathway, and the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase (MAPK) signaling pathway (5). Furthermore, it was previously proposed that TNF-α did not induce the proliferation of ASMCs (38) and may inhibit proliferation induced by other growth factors (39). This may be due to differences in species used for the experiments, the concentration of TNF-α, exposure duration and culture medium. In the present study, a positive mitogenic effect of TNF-α on ASMCs was observed and the upregulation of TRPM7 led to a proliferative effect of TNF-α. The underlying mechanism of TRPM7 regulating the proliferation of ASMCs may contribute to a potential interaction between its distinctive serine/threonine protein kinase domain, and the PI3K and MAPK signaling pathway, which consists of a cascade reaction of serine/threonine kinases (40); however, further research is required to elucidate this further.

In the current study; however, treatment with TRPM7-shRNA lentivirus vector did not completely inhibit the effect of cell proliferation and IL-8 secretion that was induced by CSE (15%) or TNF-α. Stimulation with CSE (15%) or TNF-α increased cell proliferation and IL-8 secretion in ASMCs from smoke-exposed rats when compared with normal rats in the presence of TRPM7-shRNA lentivirus vector treatment. This indicated that there is an alternative mechanism inducing the response to cigarette smoke or TNF-α in ASMCs.

In conclusion, the present study revealed that TRPM7 expression levels were elevated in ASMCs from rats exposed to cigarette smoke, and that upregulation of TRPM7 augmented cell proliferation and IL-8 secretion in ASMCs from smoke-exposed rats. ASMC proliferation and IL-8 secretion are considered to be important in the development of COPD; therefore, the current study indicates that TRPM7 may be a potential target for the treatment of COPD.

Acknowledgments

The present study was supported by the National Science Foundation of China (grant nos. 81000015 and 81370120).

References

1 

Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: gold executive summary. Am J Respir Crit Care Med. 187:347–365. 2013. View Article : Google Scholar

2 

Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A and Fabbri LM: CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 157:822–826. 1998. View Article : Google Scholar : PubMed/NCBI

3 

Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO and Paré PD: The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 350:2645–2653. 2004. View Article : Google Scholar : PubMed/NCBI

4 

Chung KF: The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2:347–354; discussion 371–372. 2005. View Article : Google Scholar : PubMed/NCBI

5 

Stamatiou R, Paraskeva E, Gourgoulianis K, Molyvdas PA and Hatziefthimiou A: Cytokines and growth factors promote airway smooth muscle cell proliferation. ISRN Inflamm. 2012:7314722012. View Article : Google Scholar : PubMed/NCBI

6 

Pera T, Gosens R, Lesterhuis AH, Sami R, van der Toorn M, Zaagsma J and Meurs H: Cigarette smoke and lipopolysaccharide induce a proliferative airway smooth muscle phenotype. Respir Res. 11:482010. View Article : Google Scholar : PubMed/NCBI

7 

Howarth PH, Knox AJ, Amrani Y, Tliba O, Panettieri RA Jr and Johnson M: Synthetic responses in airway smooth muscle. J Allergy Clin Immunol. 114(Suppl 2): S32–S50. 2004. View Article : Google Scholar : PubMed/NCBI

8 

Manetsch M, Seidel P, Heintz U, Che W, Hughes JM, Ge Q, Sukkar MB and Ammit AJ: TLR2 ligand engagement upregulates airway smooth muscle TNFα-induced cytokine production. Am J Physiol Lung Cell Mol Physiol. 302:L838–L845. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Baarsma HA, Meurs H, Halayko AJ, Menzen MH, Schmidt M, Kerstjens HA and Gosens R: Glycogen synthase kinase-3 regulates cigarette smoke extract- and IL-1β-induced cytokine secretion by airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 300:L910–L919. 2011. View Article : Google Scholar : PubMed/NCBI

10 

Gosens R, Rieks D, Meurs H, Ninaber DK, Rabe KF, Nanninga J, Kolahian S, Halayko AJ, Hiemstra PS and Zuyderduyn S: Muscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells. Eur Respir J. 34:1436–1443. 2009. View Article : Google Scholar : PubMed/NCBI

11 

Clapham DE: TRP channels as cellular sensors. Nature. 426:517–524. 2003. View Article : Google Scholar : PubMed/NCBI

12 

Schmitz C, Perraud AL, Johnson CO, Inabe K, Smith MK, Penner R, Kurosaki T, Fleig A and Scharenberg AM: Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell. 114:191–200. 2003. View Article : Google Scholar : PubMed/NCBI

13 

Runnels LW, Yue L and Clapham DE: TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science. 291:1043–1047. 2001. View Article : Google Scholar : PubMed/NCBI

14 

Fonfria E, Murdock PR, Cusdin FS, Benham CD, Kelsell RE and McNulty S: Tissue distribution profiles of the human TRPM cation channel family. J Recept Signal Transduct Res. 26:159–178. 2006. View Article : Google Scholar : PubMed/NCBI

15 

Kunert-Keil C, Bisping F, Krüger J and Brinkmeier H: Tissue-specific expression of TRP channel genes in the mouse and its variation in three different mouse strains. BMC Genomics. 7:1592006. View Article : Google Scholar : PubMed/NCBI

16 

Visser D, Middelbeek J, van Leeuwen FN and Jalink K: Function and regulation of the channel-kinase TRPM7 in health and disease. Eur J Cell Biol. 93:455–465. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Huang L, Ng NM, Chen M, Lin X, Tang T, Cheng H, Yang C and Jiang S: Inhibition of TRPM7 channels reduces degranulation and release of cytokines in rat bone marrow-derived mast cells. Int J Mol Sci. 15:11817–11831. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Chen M, Shi JT, Lv ZQ, Huang LJ, Lin XL, Zhang W, Liang RY, Li YQ and Jiang SP: Triptolide inhibits TGF-β1 induced proliferation and migration of rat airway smooth muscle cells by suppressing NF-κB but not ERK1/2. Immunology. Sep 29–2014.Epub ahead of print. View Article : Google Scholar

19 

Chen M, Lv Z, Huang L, Zhang W, Lin X, Shi J, Zhang W, Liang R and Jiang S: Triptolide inhibits TGF-β1-induced cell proliferation in rat airway smooth muscle cells by suppressing Smad signaling. Exp Cell Res. 331:362–368. 2015. View Article : Google Scholar

20 

Sahni J, Tamura R, Sweet IR and Scharenberg AM: TRPM7 regulates quiescent/proliferative metabolic transitions in lymphocytes. Cell Cycle. 9:3565–3574. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Aarts M, Iihara K, Wei WL, Xiong ZG, Arundine M, Cerwinski W, MacDonald JF and Tymianski M: A key role for TRPM7 channels in anoxic neuronal death. Cell. 115:863–877. 2003. View Article : Google Scholar : PubMed/NCBI

22 

Touyz RM: Transient receptor potential melastatin 6 and 7 channels, magnesium transport and vascular biology: Implications in hypertension. Am J Physiol Heart Circ Physiol. 294:H1103–H1118. 2008. View Article : Google Scholar : PubMed/NCBI

23 

Zeng Z, Inoue K, Sun H, Leng T, Feng X, Zhu L and Xiong ZG: TRPM7 regulates vascular endothelial cell adhesion and tube formation. Am J Physiol Cell Physiol. 308:C308–C318. 2015. View Article : Google Scholar :

24 

Wykes RC, Lee M, Duffy SM, Yang W, Seward EP and Bradding P: Functional transient receptor potential melastatin 7 channels are critical for human mast cell survival. J Immunol. 179:4045–4052. 2007. View Article : Google Scholar : PubMed/NCBI

25 

Yu M, Huang C, Huang Y, Wu X, Li X and Li J: Inhibition of TRPM7 channels prevents proliferation and differentiation of human lung fibroblasts. Inflamm Res. 62:961–970. 2013. View Article : Google Scholar : PubMed/NCBI

26 

Meng Z, Cao R, Wang Y, Cao H, Liu T, Yang Z and Wang X: Suppression of renal TRPM7 may alleviate kidney injury in the renal transplantation. World J Urol. 32:1303–1311. 2014. View Article : Google Scholar

27 

Che H, Yue J, Tse HF and Li GR: Functional TRPV and TRPM channels in human preadipocytes. Pflugers Arch. 466:947–959. 2014. View Article : Google Scholar

28 

Ng NM, Jiang SP and Lv ZQ: Retrovirus-mediated siRNA targeting TRPM7 gene induces apoptosis in RBL-2H3 cells. Eur Rev Med Pharmacol Sci. 16:1172–1178. 2012.PubMed/NCBI

29 

Jiang J, Li MH, Inoue K, Chu XP, Seeds J and Xiong ZG: Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: Role in cell proliferation. Cancer Res. 67:10929–10938. 2007. View Article : Google Scholar : PubMed/NCBI

30 

Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H and Ouadid-Ahidouch H: Evidence that TRPM7 is required for breast cancer cell proliferation. Am J Physiol Cell Physiol. 297:C493–C502. 2009. View Article : Google Scholar : PubMed/NCBI

31 

Mishra R, Rao V, Ta R, Shobeiri N and Hill CE: Mg2+- and MgATP-inhibited and Ca2+/calmodulin-sensitive TRPM7-like current in hepatoma and hepatocytes. Am J Physiol Gastrointest Liver Physiol. 297:G687–G694. 2009. View Article : Google Scholar : PubMed/NCBI

32 

Kim BJ, Kim SY, Lee S, Jeon JH, Matsui H, Kwon YK, Kim SJ and So I: The role of transient receptor potential channel blockers in human gastric cancer cell viability. Can J Physiol Pharmacol. 90:175–186. 2012. View Article : Google Scholar : PubMed/NCBI

33 

Sun Y, Selvaraj S, Varma A, Derry S, Sahmoun AE and Singh BB: Increase in serum Ca2+/Mg2+ ratio promotes proliferation of prostate cancer cells by activating TRPM7 channels. J Biol Chem. 288:255–263. 2013. View Article : Google Scholar :

34 

Tanni SE, Pelegrino NR, Angeleli AY, Correa C and Godoy I: Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. J Inflamm (Lond). 7:292010. View Article : Google Scholar

35 

Chiang CH, Chuang CH and Liu SL: Transforming growth factor-β1 and tumor necrosis factor-α are associated with clinical severity and airflow limitation of COPD in an additive manner. Lung. 192:95–102. 2014. View Article : Google Scholar

36 

Churg A, Dai J, Tai H, Xie C and Wright JL: Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med. 166:849–854. 2002. View Article : Google Scholar : PubMed/NCBI

37 

Churg A, Wang RD, Tai H, Wang X, Xie C and Wright JL: Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med. 170:492–498. 2004. View Article : Google Scholar : PubMed/NCBI

38 

McKay S, Hirst SJ, Haas MB, de Jongste JC, Hoogsteden HC, Saxena PR and Sharma HS: Tumor necrosis factor-alpha enhances mRNA expression and secretion of interleukin-6 in cultured human airway smooth muscle cells. Am J Respir Cell Mol Biol. 23:103–111. 2000. View Article : Google Scholar : PubMed/NCBI

39 

Tliba O, Tliba S, Da Huang C, Hoffman RK, DeLong P, Panettieri RA Jr and Amrani Y: Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta. J Biol Chem. 278:50615–50623. 2003. View Article : Google Scholar : PubMed/NCBI

40 

Yee NS, Kazi AA and Yee RK: Cellular and developmental biology of TRPM7 channel-kinase: Implicated roles in cancer. Cells. 3:751–77. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June-2016
Volume 13 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lin X, Yang C, Huang L, Chen M, Shi J, Ouyang L, Tang T, Zhang W, Li Y, Liang R, Liang R, et al: Upregulation of TRPM7 augments cell proliferation and interleukin-8 release in airway smooth muscle cells of rats exposed to cigarette smoke. Mol Med Rep 13: 4995-5004, 2016
APA
Lin, X., Yang, C., Huang, L., Chen, M., Shi, J., Ouyang, L. ... Jiang, S. (2016). Upregulation of TRPM7 augments cell proliferation and interleukin-8 release in airway smooth muscle cells of rats exposed to cigarette smoke. Molecular Medicine Reports, 13, 4995-5004. https://doi.org/10.3892/mmr.2016.5161
MLA
Lin, X., Yang, C., Huang, L., Chen, M., Shi, J., Ouyang, L., Tang, T., Zhang, W., Li, Y., Liang, R., Jiang, S."Upregulation of TRPM7 augments cell proliferation and interleukin-8 release in airway smooth muscle cells of rats exposed to cigarette smoke". Molecular Medicine Reports 13.6 (2016): 4995-5004.
Chicago
Lin, X., Yang, C., Huang, L., Chen, M., Shi, J., Ouyang, L., Tang, T., Zhang, W., Li, Y., Liang, R., Jiang, S."Upregulation of TRPM7 augments cell proliferation and interleukin-8 release in airway smooth muscle cells of rats exposed to cigarette smoke". Molecular Medicine Reports 13, no. 6 (2016): 4995-5004. https://doi.org/10.3892/mmr.2016.5161